Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

In a randomized, double-blind clinical trial, adjuvant atorvastatin improved symptoms of depression and blood lipid values in patients suffering from severe major depressive disorder
Mohammad Haghighi, Saeed Khodakarami, Leila Jahangard, et al.
Journal of Psychiatric Research (2014) Vol. 58, pp. 109-114
Closed Access | Times Cited: 64

Showing 1-25 of 64 citing articles:

Efficacy of anti‐inflammatory treatment on major depressive disorder or depressive symptoms: meta‐analysis of clinical trials
Ole Köhler‐Forsberg, Cecilie N. Lydholm, Carsten Hjorthøj, et al.
Acta Psychiatrica Scandinavica (2019) Vol. 139, Iss. 5, pp. 404-419
Closed Access | Times Cited: 340
Cognitive remission: a novel objective for the treatment of major depression?
Beatrice Bortolato, Kamilla Woznica Miskowiak, Cristiano A. Köhler, et al.
BMC Medicine (2016) Vol. 14, Iss. 1
Open Access | Times Cited: 222
Nutritional Aspects of Depression
Undine E. Lang, Christoph Beglinger, Nina Schweinfurth, et al.
Cellular Physiology and Biochemistry (2015) Vol. 37, Iss. 3, pp. 1029-1043
Open Access | Times Cited: 220
Efficacy and safety of anti-inflammatory agents for the treatment of major depressive disorder: a systematic review and meta-analysis of randomised controlled trials
Shuang Bai, Wenliang Guo, Yangyang Feng, et al.
Journal of Neurology Neurosurgery & Psychiatry (2019) Vol. 91, Iss. 1, pp. 21-32
Closed Access | Times Cited: 178
Metabolic and inflammatory markers: associations with individual depressive symptoms
Femke Lamers, Yuri Milaneschi, Peter de Jonge, et al.
Psychological Medicine (2017) Vol. 48, Iss. 7, pp. 1102-1110
Open Access | Times Cited: 177
Statins for the treatment of depression: A meta-analysis of randomized, double-blind, placebo-controlled trials
Estela Salagre, Brisa S. Fernandes, Seetal Dodd, et al.
Journal of Affective Disorders (2016) Vol. 200, pp. 235-242
Closed Access | Times Cited: 112
Statins and Inflammation: New Therapeutic Opportunities in Psychiatry
Sung‐Wan Kim, Hee‐Ju Kang, Min Jhon, et al.
Frontiers in Psychiatry (2019) Vol. 10
Open Access | Times Cited: 109
The Role of Lipid Biomarkers in Major Depression
Amy Parekh, Demelza Smeeth, Yasmin Milner, et al.
Healthcare (2017) Vol. 5, Iss. 1, pp. 5-5
Open Access | Times Cited: 104
Association between systemic immune-inflammation index and post-stroke depression: a cross-sectional study of the national health and nutrition examination survey 2005–2020
Mingzhu Wang, Chengchao Peng, Tingting Jiang, et al.
Frontiers in Neurology (2024) Vol. 15
Open Access | Times Cited: 9
Simvastatin versus atorvastatin for improving mild to moderate depression in post-coronary artery bypass graft patients: A double-blind, placebo-controlled, randomized trial
Seyed Hesameddin Abbasi, Payam Mohammadinejad, Nazila Shahmansouri, et al.
Journal of Affective Disorders (2015) Vol. 183, pp. 149-155
Closed Access | Times Cited: 66
Youth Depression Alleviation with Anti-inflammatory Agents (YoDA-A): a randomised clinical trial of rosuvastatin and aspirin
Michael Berk, Mohammadreza Mohebbi, Olivia Dean, et al.
BMC Medicine (2020) Vol. 18, Iss. 1
Open Access | Times Cited: 54
Anti-inflammatory medications for the treatment of mental disorders: A scoping review
Rebecca Fitton, Jennifer Sweetman, William Heseltine-Carp, et al.
Brain Behavior & Immunity - Health (2022) Vol. 26, pp. 100518-100518
Open Access | Times Cited: 35
Do statins have an effect on depressive symptoms? A systematic review and meta-analysis
Megha Sai Yatham, Kavya Sai Yatham, Arun Ravindran, et al.
Journal of Affective Disorders (2019) Vol. 257, pp. 55-63
Closed Access | Times Cited: 53
Detached mindfulness reduced both depression and anxiety in elderly women with major depressive disorders
Mohammad Ahmadpanah, Tayebe Akbari, Amineh Akhondi, et al.
Psychiatry Research (2017) Vol. 257, pp. 87-94
Closed Access | Times Cited: 50
Statins in the treatment of depression: Hype or hope?
Ole Köhler‐Forsberg, Christian Otte, Stefan M. Gold, et al.
Pharmacology & Therapeutics (2020) Vol. 215, pp. 107625-107625
Closed Access | Times Cited: 40
Statins for major depressive disorder: A systematic review and meta-analysis of randomized controlled trials
Riccardo De Giorgi, Franco De Crescenzo, Nicola Rizzo Pesci, et al.
PLoS ONE (2021) Vol. 16, Iss. 3, pp. e0249409-e0249409
Open Access | Times Cited: 39
Statins in Depression: An Evidence-Based Overview of Mechanisms and Clinical Studies
Riccardo De Giorgi, Nicola Rizzo Pesci, Alice M. G. Quinton, et al.
Frontiers in Psychiatry (2021) Vol. 12
Open Access | Times Cited: 37
Rosa damascena oil improves SSRI-induced sexual dysfunction in male patients suffering from major depressive disorders: results from a double-blind, randomized, and placebo-controlled clinical trial
Serge Brand, Vahid Farnia, Jalal Shakeri, et al.
Neuropsychiatric Disease and Treatment (2015), pp. 625-625
Open Access | Times Cited: 48
Adjuvant thiamine improved standard treatment in patients with major depressive disorder: results from a randomized, double-blind, and placebo-controlled clinical trial
Ali Ghaleiha, Hassan Davari, Leila Jahangard, et al.
European Archives of Psychiatry and Clinical Neuroscience (2016) Vol. 266, Iss. 8, pp. 695-702
Closed Access | Times Cited: 44
Comparative Efficacy and Acceptability of Anti-inflammatory Agents on Major Depressive Disorder: A Network Meta-Analysis
Xiaoyi Hang, Yijie Zhang, Jingjing Li, et al.
Frontiers in Pharmacology (2021) Vol. 12
Open Access | Times Cited: 28
Cool the Inflamed Brain: A Novel Anti-inflammatory Strategy for the Treatment of Major Depressive Disorder
Wenjun Su, Ting Hu, Chun‐Lei Jiang
Current Neuropharmacology (2023) Vol. 22, Iss. 5, pp. 810-842
Closed Access | Times Cited: 12
Effect of Adjunctive Simvastatin on Depressive Symptoms Among Adults With Treatment-Resistant Depression
M. Ishrat Husain, Imran B. Chaudhry, Ameer B. Khoso, et al.
JAMA Network Open (2023) Vol. 6, Iss. 2, pp. e230147-e230147
Open Access | Times Cited: 11
Mushrooms, Microdosing, and Mental Illness: The Effect of Psilocybin on Neurotransmitters, Neuroinflammation, and Neuroplasticity
Daniel A Kinderlehrer
Neuropsychiatric Disease and Treatment (2025) Vol. Volume 21, pp. 141-155
Open Access
The use of statins for the treatment of depression in patients with acute coronary syndrome
S W Kim, Kyung‐Yeol Bae, Jong-Min Kim, et al.
Translational Psychiatry (2015) Vol. 5, Iss. 8, pp. e620-e620
Open Access | Times Cited: 38
Blockade of the angiotensin system improves mental health domain of quality of life: A meta-analysis of randomized clinical trials
Daniel J. Brownstein, Estela Salagre, Cristiano A. Köhler, et al.
Australian & New Zealand Journal of Psychiatry (2017) Vol. 52, Iss. 1, pp. 24-38
Open Access | Times Cited: 37
Page 1 - Next Page

Scroll to top